DNTH
Price
$19.50
Change
+$0.35 (+1.83%)
Updated
Aug 8, 10:30 AM (EDT)
Capitalization
615.86M
ZLAB
Price
$34.54
Change
+$0.46 (+1.35%)
Updated
Aug 8, 11:28 AM (EDT)
Capitalization
4.27B
95 days until earnings call
Interact to see
Advertisement

DNTH vs ZLAB

Header iconDNTH vs ZLAB Comparison
Open Charts DNTH vs ZLABBanner chart's image
Dianthus Therapeutics
Price$19.50
Change+$0.35 (+1.83%)
Volume$11.87K
Capitalization615.86M
Zai Lab
Price$34.54
Change+$0.46 (+1.35%)
Volume$200
Capitalization4.27B
DNTH vs ZLAB Comparison Chart in %
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. ZLAB commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a StrongBuy and ZLAB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (DNTH: $19.15 vs. ZLAB: $34.05)
Brand notoriety: DNTH and ZLAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 71% vs. ZLAB: 188%
Market capitalization -- DNTH: $615.86M vs. ZLAB: $4.27B
DNTH [@Biotechnology] is valued at $615.86M. ZLAB’s [@Biotechnology] market capitalization is $4.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileZLAB’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • ZLAB’s FA Score: 0 green, 5 red.
According to our system of comparison, ZLAB is a better buy in the long-term than DNTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 4 TA indicator(s) are bullish while ZLAB’s TA Score has 2 bullish TA indicator(s).

  • DNTH’s TA Score: 4 bullish, 5 bearish.
  • ZLAB’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than ZLAB.

Price Growth

DNTH (@Biotechnology) experienced а -7.35% price change this week, while ZLAB (@Biotechnology) price change was -9.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

ZLAB is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZLAB($4.27B) has a higher market cap than DNTH($616M). ZLAB YTD gains are higher at: 30.011 vs. DNTH (-12.156). DNTH has higher annual earnings (EBITDA): -116.76M vs. ZLAB (-236.44M). ZLAB has more cash in the bank: 757M vs. DNTH (263M). DNTH has less debt than ZLAB: DNTH (1.4M) vs ZLAB (192M). ZLAB has higher revenues than DNTH: ZLAB (418M) vs DNTH (6.52M).
DNTHZLABDNTH / ZLAB
Capitalization616M4.27B14%
EBITDA-116.76M-236.44M49%
Gain YTD-12.15630.011-41%
P/E Ratio3.24N/A-
Revenue6.52M418M2%
Total Cash263M757M35%
Total Debt1.4M192M1%
FUNDAMENTALS RATINGS
DNTH vs ZLAB: Fundamental Ratings
DNTH
ZLAB
OUTLOOK RATING
1..100
7015
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
48
Fair valued
PROFIT vs RISK RATING
1..100
55100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
5838
P/E GROWTH RATING
1..100
68100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZLAB's Valuation (48) in the Biotechnology industry is in the same range as DNTH (50) in the null industry. This means that ZLAB’s stock grew similarly to DNTH’s over the last 12 months.

DNTH's Profit vs Risk Rating (55) in the null industry is somewhat better than the same rating for ZLAB (100) in the Biotechnology industry. This means that DNTH’s stock grew somewhat faster than ZLAB’s over the last 12 months.

DNTH's SMR Rating (96) in the null industry is in the same range as ZLAB (97) in the Biotechnology industry. This means that DNTH’s stock grew similarly to ZLAB’s over the last 12 months.

ZLAB's Price Growth Rating (38) in the Biotechnology industry is in the same range as DNTH (58) in the null industry. This means that ZLAB’s stock grew similarly to DNTH’s over the last 12 months.

DNTH's P/E Growth Rating (68) in the null industry is in the same range as ZLAB (100) in the Biotechnology industry. This means that DNTH’s stock grew similarly to ZLAB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHZLAB
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 22 days ago
79%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IIRMX10.61N/A
N/A
Voya Russell Mid Cap Index Port I
EICCX17.91N/A
N/A
EIC Value C
LSVGX15.89N/A
N/A
LSV Global Value Institutional
TCIWX26.38N/A
N/A
Nuveen International Eq Idx W
CGIIX50.15-0.03
-0.06%
Calamos Growth & Income I

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMNM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-6.08%
IMNM - DNTH
54%
Loosely correlated
-5.64%
XNCR - DNTH
51%
Loosely correlated
-2.27%
SYRE - DNTH
48%
Loosely correlated
-4.51%
CRNX - DNTH
48%
Loosely correlated
-2.28%
ERAS - DNTH
48%
Loosely correlated
+2.10%
More